News
Immune Approaches Hold Great Promise in Myeloma, Expert Says
Over the past 5 years, several therapies have been developed that have proven to be effective for patients with multiple myeloma. The FDA has...
Patient/Caregiver Survey
Please take 10 minutes to complete this survey to help us put myeloma on New Zealand’s health agenda and help you to have the best lives possible....
Pediatric Guidelines for CAR T-Cell Therapy Help Nurses Recognize AEs Earlier
A year after the first CAR T-cell therapy was approved to treat pediatric patients with relapsed and/or refractory CD19-positive acute lymphoblastic...
Elotuzumab Triplet Granted Priority Review by FDA for Myeloma
A supplemental biologics license application (sBLA) for elotuzumab (Empliciti) has been granted a priority review by the FDA for use in combination...
New Research to Explore ‘On and Off’ Switch for CAR T-Cell Therapy
Researchers are working on an “on and off” switch to improve the safety and efficacy of chimeric antigen receptor (CAR) T-cell therapy and counter...
Dr. Madduri on Eligibility for CAR T-Cell Therapy in Myeloma
Deepu Madduri, MD, assistant professor, Mount Sinai Hospital, discusses eligibly criteria for patients with multiple myeloma to receive chimeric...
Want to make better T-cell therapies? First, figure out how they work
These man-made cancer-fighting molecules are infinitely variable, like a set of Legos, each one constructed to allow a patient’s immune cells to...
First in-depth profile of CAR T-cell signals suggests how to improve immunotherapy
CAR T-cell therapy, which reprograms immune cells to fight cancer, has shown great promise in people with some blood cancers who have not responded...
Selinexor and Multiple Myeloma
There are various treatment options for patients with multiple myeloma (MM), including autologous hematopoietic stem cell transplantation (HSCT),...
Georgia woman hopes experimental “living” cancer therapy will stop her myeloma
For 48-year old Atlanta mom, wife and dog groomer Cheri Letts, the realization she was sick came slowly. "I was starting to feel rundown, and it...
Advances Could Lead to Curative Strategies in Myeloma
There are currently 10 FDA-approved treatments in the multiple myeloma space; however, a more personalized therapy could be key to finding a cure,...
Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis
Background: The refractory/relapsed multiple myeloma (RRMM) remains a big clinical challenge, due to its biological and clinical complexity. Leading...